Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₩ 280
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical and Bio business divisions. The Pharmaceutical business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio business division manufactures biopharmaceuticals. The company was founded on December 3,...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Data is available to registered users only
Buy
Sell